{
  "executiveSummary": "<ul><li>Actuals are reported through the last completed whole month (Dec 2025); all periods beyond are forecast.</li><li>ARR £9.4m, up 70% YoY; recurring revenue is 94% of total and gross margin 78%.</li><li>Efficiency mixed: Rule of 40 at 63% and CAC ratio 0.56 (strong), but NRR at 90% and gross retention 79% indicate churn/downsell pressure.</li><li>Q4 actual ARR net +£506k with +4 net logos; losses concentrated in Finance & Professional Services and Africa/North America.</li><li>P&L: FY EBITDA -£595k, beating budget by £30k (5%); Q4 and Dec both outperformed budget (EBITDA beats of 59% and 34%).</li><li>Outlook: EBIT turns positive from H1 FY26; headcount scales from 64 to 106 by FY27 while maintaining 78% gross margin.</li><li>Immediate focus: arrest retention drag (lift NRR >95%), protect Finance & Professional Services, and reinvest S&M efficiency to accelerate high-ROI “Energy & Utilities” and “Life Science” wins.</li></ul>",
  "page1": "<ul><li>Scale and growth: ARR £9.4m; customers 96; avg ARR £98k; ARR per head 147 vs 77 benchmark (strong productivity).</li><li>Margins: Gross 78% (>72 benchmark); recurring margin 83%; non‑recurring margin 4% (tiny by design as mix is 94% recurring).</li><li>Retention: Logo 85% (<91 benchmark); gross retention 79%; NRR 90%—key headwind to compounding.</li><li>Spend mix: S&M 37% (>32 benchmark); R&D 28% (<33 benchmark); G&A 20% (<22 benchmark). EBIT -7% (near breakeven as we scale).</li><li>Unit economics: CAC ratio 0.56 and LTV:CAC 6.5—room to lean into efficient customer acquisition while fixing retention.</li><li>Actions: tighten save-at-risk motions; targeted price/packaging to curb downsell; redeploy a portion of S&M to Customer Success until NRR >95%.</li></ul>",
  "page2": "<ul><li>Logos: 96 at Dec 2025; +8 new and -4 lost in the last quarter; trajectory to 168 by Dec 2027.</li><li>ARR bridge (Dec quarter): Land £720k, Expand £236k, Downsells -£45k, Attrition -£405k → Net +£506k to £9.4m.</li><li>Retention metrics (Dec 2025): Logo retention 96% for the quarter but rolling NRR 90% (Page 4), indicating volume gains offset by value leakage.</li><li>Growth cadence: Quarterly growth 6% in Dec 2025, then 10%+ cadence resuming through FY26; ARR forecast £17.6m by Dec 2027.</li><li>Actions: increase price realization in renewal cohorts; focus land-to-expand playbooks given strong new logo performance and efficient CAC.</li></ul>",
  "page3": "<ul><li>P&L (Dec 2025): Revenue £8.38m; Gross margin £6.58m (78%); S&M £3.10m (37%); R&D £2.36m (28%); G&A £1.71m (20%); EBIT -£0.60m (-7%).</li><li>Efficiency: Rule of 40 63%; CAC ratio 0.56; LTV:CAC 6.5—profitable growth line-of-sight once retention improves.</li><li>Trend and outlook: EBIT turns positive from Jun 2026 and reaches 6% by Dec 2027 while maintaining 78% GM.</li><li>Headcount: 64 at Dec 2025; forecast 106 by Dec 2027 (investment weighted to R&D and GTM).</li><li>Actions: hold S&M at ~35–37% of revenue unless NRR >95%; sequence hiring to Customer Success and data/AI product value to lift expansion.</li></ul>",
  "page4": "<ul><li>Rolling ARR growth: +70% YoY to £9.4m; ARR net +£3.88m over the last 12 months driven by £4.41m lands and £0.62m upsell offset by -£1.15m churn/downsell.</li><li>Vertical mix: Energy & Utilities £3.95m (lead engine), Life Science £2.50m, Government £1.31m; Finance & Professional Services £0.90m; 3rd Sector & Education £0.77m.</li><li>Geography: South America £2.18m, Asia £2.09m, North America £1.87m, Africa £1.86m, Europe £1.42m—balanced footprint with concentration in E&U across multiple regions.</li><li>NRR trend: rolling NRR at 90% after mid-year dips; requires targeted save/expansion in at-risk cohorts (see Page 5 losses).</li><li>Customer grid: expansions broadly distributed (many +£90k steps), but visible Oct downsell (-£45k) and sporadic churn pockets.</li><li>Actions: double down on Energy & Utilities/Life Science vertical playbooks; implement region-specific retention plans in Africa and North America where losses spiked in Q4.</li></ul>",
  "page5": "<ul><li>Last 3 months (Oct–Dec 2025): Net +£506k ARR and +4 logos—New £720k (8 logos), Expand £236k, Downsells -£45k, Lost -£405k (4 logos).</li><li>By vertical: Energy & Utilities +£461k (growth driver); Government +£135k; Life Science +£180k; Finance & Professional Services -£360k from 4 lost logos—primary risk area; 3rd Sector +£90k.</li><li>By region: North America +£315k and South America +£135k offset by Africa -£34k; Asia +£90k—losses concentrated in Africa and North America.</li><li>Customer signals: four logo losses at £-90k each (Customers 175, 215, 83, 435); one downsell -£45k (Customer 259); broad-based +£90k lands/expands across multiple customers.</li><li>Implications: headline growth remains healthy, but Q4 value leakage capped NRR; Finance & Professional Services and select African/NA accounts need immediate intervention.</li><li>Actions (next 60 days): executive outreach on lost and at‑risk F&PS accounts; deploy win‑back offers; CS playbooks for price/seat backfill; root-cause review on churn (product fit vs service vs pricing).</li></ul>",
  "page6": "<ul><li>Annual vs Budget (FY2025): Revenue +£122k (+1%); Gross margin +£63k (+1%); EBITDA -£595k vs -£625k budget → +£30k beat (5%).</li><li>Q4 vs Budget: EBITDA -£53k vs -£128k → +£76k (59% beat); Dec month beat +£18k (34%).</li><li>Cost variances: S&M £405k under budget (12% better); R&D £113k over (5%); G&A £468k over (38%)—shifted spend and inflationary overheads.</li><li>ARR vs Budget: Net +£381k (+11%); drivers—Additions +£329k and better-than-plan attrition (+£115k), partially offset by lower upsell (-£41k) and higher downsell (-£22k).</li><li>Read‑through: growth efficiency exceeded plan despite softer upsell; upside if NRR normalizes to ≥95% with current CAC efficiency.</li><li>Actions: hold S&M efficiency while re‑investing a portion into expansion programs; tighten G&A run‑rate controls; OKR to lift upsell by packaging/usage tiers in H1 FY26.</li></ul>"
}